Stella Chemifa Corporation

Tokyo Stock Exchange 4109.T

Stella Chemifa Corporation EBITDA Margin for the year ending March 31, 2024: 17.77%

Stella Chemifa Corporation EBITDA Margin is 17.77% for the year ending March 31, 2024, a 2.93% change year over year. EBITDA Ratio is the proportion of Earnings Before Interest, Taxes, Depreciation, and Amortization to total revenue, assessing a company's operational profitability before non-operating expenses and non-cash charges.

Stella Chemifa Corporation EBITDA Margin for the year ending March 31, 2023 was 17.26%, a -11.71% change year over year.
Stella Chemifa Corporation EBITDA Margin for the year ending March 31, 2022 was 19.55%, a -9.55% change year over year.
Stella Chemifa Corporation EBITDA Margin for the year ending March 31, 2021 was 21.61%, a 29.18% change year over year.
Stella Chemifa Corporation EBITDA Margin for the year ending March 31, 2020 was 16.73%, a -5.24% change year over year.

Key data

Date	EBITDA Margin	EBIT Margin	Depreciation and Amortization	EBIT

Tokyo Stock Exchange: 4109.T

Stella Chemifa Corporation

CEO	Ms. Aki Hashimoto
IPO Date	Jan. 4, 2001
Location	Japan
Headquarters	Meiji Yasuda Seimei Osaka Midosuji Bldg
Employees	695
Sector	Materials
Industries Chemicals & Advanced Materials Petrochemicals Pharmaceuticals

Description

Stella Chemifa Corporation manufactures and sells inorganic fluorine compounds in Japan and internationally. It offers hydrofluoric acid, buffered hydrofluoric acid, and etching solutions used in semiconductors, liquid crystal products, and solar batteries; calcium, aluminum, lithium, strontium, barium, magnesium, zinc, and lead fluoride used in optical materials; and lithium hexafluorophosphate for batteries. The company also provides boron trifluoride, boron trifluoride diethyl ether, boron trifluoride dimethyl ether, boron trifluoride n-butyl ether, boron trifluoride tetrahydrofuran, boron trifluoride phenol, boron trifluoride monoethyl amine, boron trifluoride piperidine, and triethylamine 3HF used in reactive catalysts; and anhydrous hydrofluoric acid and 55% hydrofluoric acid used in surface treatment and alternatives for CFCs. In addition, it offers potassium fluoroborate and boric acid for nuclear energy applications; tin fluoride (II) USP used in GMP-compliant products; and other products, such as fluorosilicic acid, potassium fluorosilicate, ammonium fluorosilicate, fluoroboric acid, tin fluoroborate, copper fluoroborate, lead fluoroborate, zinc fluoroborate, sodium fluoroborate, potassium fluoroborate, ammonium hydrogenfluoride, sodium fluoride, potassium fluoride, ammonium fluoride, potassium hexafluorozirconate, potassium hexafluorotitanate, refined calcium fluoride, and potassium hexafluorophosphate. Further, the company transports a range of special chemical substances, high-pressure gas, hazardous materials, and related products. Additionally, it develops Boron Neutron Capture therapy for the treatment of cancer. The company was formerly known as Hashimoto Chemical Corporation and changed its name to Stella Chemifa Corporation in 1997. Stella Chemifa Corporation was founded in 1916 and is headquartered in Osaka, Japan.

Key trends

Past 5 years